Research compounds, also often referred to as "research chem" or "novel compounds," represent a fairly new area of scientific investigation. They are typically created by labs, frequently outside established pharmaceutical channels, and aren't yet fully investigated for human consumption or applicat

Newly developed retatrutide, a combined-action drug targeting both GLP-1 and GIP receptors, is creating considerable buzz within the weight loss community. Early clinical studies have demonstrated substantial reductions in physical weight and advancements in metabolic markers for people with excess